White matter hyperintensity topography in Alzheimer's disease and links to cognition

Alzheimers Dement. 2022 Mar;18(3):422-433. doi: 10.1002/alz.12410. Epub 2021 Jul 28.

Abstract

Introduction: White matter hyperintensities (WMH) are often described in Alzheimer's disease (AD), but their topography and specific relationships with cognition remain unclear.

Methods: Regional WMH were estimated in 54 cognitively impaired amyloid beta-positive AD (Aβpos-AD), compared to 40 cognitively unimpaired amyloid beta-negative older controls (Aβneg-controls) matched for vascular risk factors. The cross-sectional association between regional WMH volume and cognition was assessed within each group, controlling for cerebral amyloid burden, global cortical atrophy, and hippocampal atrophy.

Results: WMH volume was larger in Aβpos-AD compared to Aβneg-controls in all regions, with the greatest changes in the splenium of the corpus callosum (S-CC). In Aβpos-AD patients, larger total and regional WMH volume, especially in the S-CC, was strongly associated with decreased cognition.

Discussion: WMH specifically contribute to lower cognition in AD, independently from amyloid deposition and atrophy. This study emphasizes the clinical relevance of WMH in AD, especially posterior WMH, and most notably S-CC WMH.

Keywords: Alzheimer's disease; amyloid positron emission tomography; cognition; corpus callosum; executive functions; fluid-attenuated inversion recovery; magnetic resonance imaging; memory; splenium; white matter hyperintensities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / pathology
  • Amyloid beta-Peptides
  • Atrophy / pathology
  • Cognition
  • Cross-Sectional Studies
  • Humans
  • Magnetic Resonance Imaging
  • White Matter* / diagnostic imaging
  • White Matter* / pathology

Substances

  • Amyloid beta-Peptides